{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T17:35:16Z","timestamp":1793036116606,"version":"4.5.0"},"reference-count":32,"publisher":"American Association for Cancer Research (AACR)","issue":"15","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2010,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Peripheral T-cell lymphomas (PTCL) constitute a major treatment problem with high mortality rates due to the minimal effectiveness of conventional chemotherapy. Recent findings identified ITK-SYK as the first recurrent translocation in 17% of unspecified PTCLs and showed the overexpression of SYK in more than 90% of PTCLs. Here, we show that the expression of ITK-SYK in the bone marrow of BALB\/c mice causes a T-cell lymphoproliferative disease in all transplanted mice within 8 weeks after transplantation. The disease was characterized by the infiltration of spleen, lymph nodes, bone marrow, and skin with CD3+CD4+CD8\u2212 and CD3+CD4\u2212CD8\u2212 ITK-SYK\u2013positive T-cells accompanied by a systemic inflammatory reaction with upregulation of interleukin 5 and INF-\u03b3. ITK-SYK\u2013positive T-cells showed enhanced apoptosis resistance and INF-\u03b3 production in vitro. The disease was serially transplantable, inducing clonal T-cell expansion in secondary recipients. The action of ITK-SYK in vivo was dependent on SYK kinase activity and disease development could be inhibited by the treatment of mice with SYK inhibitors. Interestingly, the translocation of ITK-SYK from the membrane to the cytoplasm, using a point mutation in the pleckstrin homology domain (ITK-SYK R29C), did not abolish, but rather, enhanced disease development in transplanted mice. CBL binding was strongly enhanced in membrane-associated ITK-SYK E42K and was causative for delayed disease development. Our results show that ITK-SYK causes a T-cell lymphoproliferative disease in mice, supporting its role in T-cell lymphoma development in humans. Therefore, pharmacologic inhibition of SYK in patients with U-PTCLs carrying the ITK-SYK fusion protein might be an effective treatment strategy. Cancer Res; 70(15); 6193\u2013204. \u00a92010 AACR.<\/jats:p>","DOI":"10.1158\/0008-5472.can-08-3719","type":"journal-article","created":{"date-parts":[[2010,7,29]],"date-time":"2010-07-29T05:03:43Z","timestamp":1280379823000},"page":"6193-6204","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":77,"title":["The ITK-SYK Fusion Oncogene Induces a T-Cell Lymphoproliferative Disease in Mice Mimicking Human Disease"],"prefix":"10.1158","volume":"70","author":[{"given":"Christine","family":"Dierks","sequence":"first","affiliation":[{"name":"Authors' Affiliations:\u20081Hematology\/Oncology and 2Pathology, University of Freiburg, Freiburg, Germany; 3Kinase Biology, Department of Pharmacology and Department of Medicinal Chemistry, Genomics Institute of the Novartis Research Foundation, San Diego, California; and 4Novartis Institute for Biomedical Research, Cambridge, Massachusetts"},{"name":"Authors' Affiliations:\u20081Hematology\/Oncology and 2Pathology, University of Freiburg, Freiburg, Germany; 3Kinase Biology, Department of Pharmacology and Department of Medicinal Chemistry, Genomics Institute of the Novartis Research Foundation, San Diego, California; and 4Novartis Institute for Biomedical Research, Cambridge, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Adrian","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Hematology\/Oncology and 2Pathology, University of Freiburg, Freiburg, Germany; 3Kinase Biology, Department of Pharmacology and Department of Medicinal Chemistry, Genomics Institute of the Novartis Research Foundation, San Diego, California; and 4Novartis Institute for Biomedical Research, Cambridge, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Fisch","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Hematology\/Oncology and 2Pathology, University of Freiburg, Freiburg, Germany; 3Kinase Biology, Department of Pharmacology and Department of Medicinal Chemistry, Genomics Institute of the Novartis Research Foundation, San Diego, California; and 4Novartis Institute for Biomedical Research, Cambridge, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Ma","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Hematology\/Oncology and 2Pathology, University of Freiburg, Freiburg, Germany; 3Kinase Biology, Department of Pharmacology and Department of Medicinal Chemistry, Genomics Institute of the Novartis Research Foundation, San Diego, California; and 4Novartis Institute for Biomedical Research, Cambridge, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helga","family":"Maurer","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Hematology\/Oncology and 2Pathology, University of Freiburg, Freiburg, Germany; 3Kinase Biology, Department of Pharmacology and Department of Medicinal Chemistry, Genomics Institute of the Novartis Research Foundation, San Diego, California; and 4Novartis Institute for Biomedical Research, Cambridge, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieter","family":"Herchenbach","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Hematology\/Oncology and 2Pathology, University of Freiburg, Freiburg, Germany; 3Kinase Biology, Department of Pharmacology and Department of Medicinal Chemistry, Genomics Institute of the Novartis Research Foundation, San Diego, California; and 4Novartis Institute for Biomedical Research, Cambridge, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine Ulrike","family":"Forster","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Hematology\/Oncology and 2Pathology, University of Freiburg, Freiburg, Germany; 3Kinase Biology, Department of Pharmacology and Department of Medicinal Chemistry, Genomics Institute of the Novartis Research Foundation, San Diego, California; and 4Novartis Institute for Biomedical Research, Cambridge, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Sprissler","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Hematology\/Oncology and 2Pathology, University of Freiburg, Freiburg, Germany; 3Kinase Biology, Department of Pharmacology and Department of Medicinal Chemistry, Genomics Institute of the Novartis Research Foundation, San Diego, California; and 4Novartis Institute for Biomedical Research, Cambridge, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoxun","family":"Liu","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Hematology\/Oncology and 2Pathology, University of Freiburg, Freiburg, Germany; 3Kinase Biology, Department of Pharmacology and Department of Medicinal Chemistry, Genomics Institute of the Novartis Research Foundation, San Diego, California; and 4Novartis Institute for Biomedical Research, Cambridge, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Rottmann","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Hematology\/Oncology and 2Pathology, University of Freiburg, Freiburg, Germany; 3Kinase Biology, Department of Pharmacology and Department of Medicinal Chemistry, Genomics Institute of the Novartis Research Foundation, San Diego, California; and 4Novartis Institute for Biomedical Research, Cambridge, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gui-Rong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zirlik","family":"Katja","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Hematology\/Oncology and 2Pathology, University of Freiburg, Freiburg, Germany; 3Kinase Biology, Department of Pharmacology and Department of Medicinal Chemistry, Genomics Institute of the Novartis Research Foundation, San Diego, California; and 4Novartis Institute for Biomedical Research, Cambridge, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendrik","family":"Veelken","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Hematology\/Oncology and 2Pathology, University of Freiburg, Freiburg, Germany; 3Kinase Biology, Department of Pharmacology and Department of Medicinal Chemistry, Genomics Institute of the Novartis Research Foundation, San Diego, California; and 4Novartis Institute for Biomedical Research, Cambridge, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Warmuth","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Hematology\/Oncology and 2Pathology, University of Freiburg, Freiburg, Germany; 3Kinase Biology, Department of Pharmacology and Department of Medicinal Chemistry, Genomics Institute of the Novartis Research Foundation, San Diego, California; and 4Novartis Institute for Biomedical Research, Cambridge, Massachusetts"},{"name":"Authors' Affiliations:\u20081Hematology\/Oncology and 2Pathology, University of Freiburg, Freiburg, Germany; 3Kinase Biology, Department of Pharmacology and Department of Medicinal Chemistry, Genomics Institute of the Novartis Research Foundation, San Diego, California; and 4Novartis Institute for Biomedical Research, Cambridge, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2010,7,28]]},"reference":[{"key":"2022061701495678400_bib1","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1182\/asheducation-2004.1.80","article-title":"The molecular basis of leukemia","author":"Gilliland","year":"2004","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"2022061701495678400_bib2","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/path.2209","article-title":"Sarcomas: genetics, signalling, and cellular origins. Part 1: the fellowship of TET","volume":"213","author":"Riggi","year":"2007","journal-title":"J Pathol"},{"key":"2022061701495678400_bib3","first-page":"1955","article-title":"Evidence that the phl gene encodes a 160,000-dalton phosphoprotein with associated kinase activity","volume":"7","author":"Stam","year":"1987","journal-title":"Mol Cell Biol"},{"key":"2022061701495678400_bib4","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nm0596-561","article-title":"Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells","volume":"2","author":"Druker","year":"1996","journal-title":"Nat Med"},{"key":"2022061701495678400_bib5","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/sj.leu.2404045","article-title":"Novel t(5;9)(q33;q22) fuses ITK to SYK in unspecified peripheral T-cell lymphoma","volume":"20","author":"Streubel","year":"2006","journal-title":"Leukemia"},{"key":"2022061701495678400_bib6","first-page":"481","article-title":"Peripheral T-cell lymphomas","volume":"19","author":"Feller","year":"1991","journal-title":"Histopathology"},{"key":"2022061701495678400_bib7","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/385093a0","article-title":"Regulatory intramolecular association in a tyrosine kinase of the Tec family","volume":"385","author":"Andreotti","year":"1997","journal-title":"Nature"},{"key":"2022061701495678400_bib8","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.4049\/jimmunol.169.5.2397","article-title":"NK T cell precursors exhibit differential cytokine regulation and require Itk for efficient maturation","volume":"169","author":"Gadue","year":"2002","journal-title":"J Immunol"},{"key":"2022061701495678400_bib9","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1128\/MCB.16.4.1305","article-title":"Phospholipase C-\u03b31 interacts with conserved phosphotyrosyl residues in the linker region of Syk and is a substrate for Syk","volume":"16","author":"Law","year":"1996","journal-title":"Mol Cell Biol"},{"key":"2022061701495678400_bib10","doi-asserted-by":"crossref","first-page":"35442","DOI":"10.1074\/jbc.M004549200","article-title":"Phosphorylation of Syk activation loop tyrosines is essential for Syk function. An in vivo study using a specific anti-Syk activation loop phosphotyrosine antibody","volume":"275","author":"Zhang","year":"2000","journal-title":"J Biol Chem"},{"key":"2022061701495678400_bib11","doi-asserted-by":"crossref","first-page":"4366","DOI":"10.4049\/jimmunol.161.8.4366","article-title":"Mutations in the activation loop tyrosines of protein tyrosine kinase Syk abrogate intracellular signaling but not kinase activity","volume":"161","author":"Zhang","year":"1998","journal-title":"J Immunol"},{"key":"2022061701495678400_bib12","doi-asserted-by":"crossref","first-page":"4510","DOI":"10.1074\/jbc.M410326200","article-title":"Distinct roles for the linker region tyrosines of Syk in Fc\u03f5RI signaling in primary mast cells","volume":"280","author":"Simon","year":"2005","journal-title":"J Biol Chem"},{"key":"2022061701495678400_bib13","doi-asserted-by":"crossref","first-page":"10751","DOI":"10.1074\/jbc.272.16.10751","article-title":"Tyrosine phosphorylation of the vav proto-oncogene product links Fc\u03f5RI to the Rac1-JNK pathway","volume":"272","author":"Teramoto","year":"1997","journal-title":"J Biol Chem"},{"key":"2022061701495678400_bib14","first-page":"2595","article-title":"Critical role for the tyrosine kinase Syk in signalling through the high affinity IgE receptor of mast cells","volume":"13","author":"Costello","year":"1996","journal-title":"Oncogene"},{"key":"2022061701495678400_bib15","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1073\/pnas.97.4.1713","article-title":"Role of Syk in B-cell development and antigen-receptor signaling","volume":"97","author":"Cornall","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022061701495678400_bib16","doi-asserted-by":"crossref","first-page":"4434","DOI":"10.1128\/MCB.17.8.4434","article-title":"Regulation of T-cell antigen receptor signalling by Syk tyrosine protein kinase","volume":"17","author":"Latour","year":"1997","journal-title":"Mol Cell Biol"},{"key":"2022061701495678400_bib17","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1084\/jem.181.6.1997","article-title":"Syk and ZAP-70 mediate recruitment of p56lck\/CD4 to the activated T cell receptor\/CD3\/\u03b6 complex","volume":"181","author":"Thome","year":"1995","journal-title":"J Exp Med"},{"key":"2022061701495678400_bib18","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/0161-5890(96)84609-8","article-title":"Differential regulation of p72syk expression in naive and proliferating CD4-8+ T cells","volume":"33","author":"Orchansky","year":"1996","journal-title":"Mol Immunol"},{"key":"2022061701495678400_bib19","doi-asserted-by":"crossref","first-page":"4758","DOI":"10.4049\/jimmunol.152.10.4758","article-title":"Differential expression of ZAP-70 and Syk protein tyrosine kinases, and the role of this family of protein tyrosine kinases in TCR signaling","volume":"152","author":"Chan","year":"1994","journal-title":"J Immunol"},{"key":"2022061701495678400_bib20","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.4049\/jimmunol.163.5.2610","article-title":"Pre-T cell receptor signals are responsible for the down-regulation of Syk protein tyrosine kinase expression","volume":"163","author":"Chu","year":"1999","journal-title":"J Immunol"},{"key":"2022061701495678400_bib21","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1038\/leu.2008.77","article-title":"Overexpression of Syk tyrosine kinase in peripheral T-cell lymphomas","volume":"22","author":"Feldman","year":"2008","journal-title":"Leukemia"},{"key":"2022061701495678400_bib22","doi-asserted-by":"crossref","first-page":"4319","DOI":"10.1073\/pnas.90.9.4319","article-title":"The sizes of the CDR3 hypervariabl regions of the murine T-cell receptor \u03b2 chains vary as a function of the recombined germ-line segments","volume":"90","author":"Pannetier","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022061701495678400_bib23","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1084\/jem.20021686","article-title":"Cbl-b negatively regulates B cell antigen receptor signaling in mature B cells through ubiquitination of the tyrosine kinase Syk","volume":"197","author":"Sohn","year":"2003","journal-title":"J Exp Med"},{"key":"2022061701495678400_bib24","doi-asserted-by":"crossref","first-page":"35273","DOI":"10.1074\/jbc.273.52.35273","article-title":"Cbl-mediated negative regulation of the Syk tyrosine kinase. A critical role for Cbl phosphotyrosine-binding domain binding to Syk phosphotyrosine 323","volume":"273","author":"Lupher","year":"1998","journal-title":"J Biol Chem"},{"key":"2022061701495678400_bib25","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1182\/blood.V97.4.1050","article-title":"Constitutive kinase activation of the TEL-Syk fusion gene in myelodysplastic syndrome with t(9;12)(q22;p12)","volume":"97","author":"Kuno","year":"2001","journal-title":"Blood"},{"key":"2022061701495678400_bib26","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/sj.leu.2403266","article-title":"TEL-Syk fusion constitutively activates PI3-K\/Akt, MAPK and JAK2-independent STAT5 signal pathways","volume":"18","author":"Kanie","year":"2004","journal-title":"Leukemia"},{"key":"2022061701495678400_bib27","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1084\/jem.20060967","article-title":"Deregulated Syk inhibits differentiation and induces growth factor-independent proliferation of pre-B cells","volume":"203","author":"Wossning","year":"2006","journal-title":"J Exp Med"},{"key":"2022061701495678400_bib28","doi-asserted-by":"crossref","first-page":"26871","DOI":"10.1074\/jbc.M109.034272","article-title":"The lymphoma-associated fusion tyrosine kinase ITK-SYK requires pleckstrin homology domain-mediated membrane localization for activation and cellular transformation","volume":"284","author":"Rigby","year":"2009","journal-title":"J Biol Chem"},{"key":"2022061701495678400_bib29","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1006\/bbrc.1999.1407","article-title":"Pleckstrin homology domains of tec family protein kinases","volume":"265","author":"Okoh","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"2022061701495678400_bib30","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1182\/blood.V97.5.1352","article-title":"SH2 domain-mediated targeting, but not localization, of Syk in the plasma membrane is critical for Fc\u03f5RI signaling","volume":"97","author":"Sada","year":"2001","journal-title":"Blood"},{"key":"2022061701495678400_bib31","doi-asserted-by":"crossref","first-page":"111","DOI":"10.4049\/jimmunol.178.1.111","article-title":"Spleen tyrosine kinase (Syk), a novel target of curcumin, is required for B lymphoma growth","volume":"178","author":"Gururajan","year":"2007","journal-title":"J Immunol"},{"key":"2022061701495678400_bib32","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0006-291X(89)91060-7","article-title":"Piceatannol (3,4,3\u2032,5\u2032-tetrahydroxy-trans-stilbene) is a naturally occurring protein-tyrosine kinase inhibitor","volume":"165","author":"Geahlen","year":"1989","journal-title":"Biochem Biophys Res Comm"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/70\/15\/6193\/2633621\/6193.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/70\/15\/6193\/2633621\/6193.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T08:54:33Z","timestamp":1685696073000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/70\/15\/6193\/559343\/The-ITK-SYK-Fusion-Oncogene-Induces-a-T-Cell"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7,28]]},"references-count":32,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2010,7,28]]},"published-print":{"date-parts":[[2010,8,1]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-08-3719","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.22380546.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22380543","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22380546","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22380543.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6499593","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6499593.v1","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,7,28]]}}}